ArticleBreast cancer (Tokyo, Japan)2023

HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

Samia Kada Mohammed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.